Ki-67-directed antisense therapy in an orthotopic renal cell carcinoma model.

Kausch, I; Jiang, H; Brocks, C; Bruderek, K; Krüger, S; Sczakiel, G; Jocham, D; Böhle, A

Kausch, I; Jiang, H; Brocks, C; Bruderek, K; Krüger, S; Sczakiel, G; Jocham, D; Böhle, A.

Affiliation

Kausch I; Department of Urology, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany. IKausch@aol.com

Eur Urol ; 46(1): 118-24; discussion 124-5, 2004 Jul.

Article in En | MEDLINE | ID: mdl-15183557

Subject(s)

Carcinoma, Renal Cell/therapy; Genetic Therapy; Ki-67 Antigen/genetics; Urinary Bladder Neoplasms/therapy; Animals; Cell Division; Disease Models, Animal; Genetic Therapy/methods; Mice; Oligonucleotides, Antisense; RNA, Messenger; Tumor Cells, Cultured

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Renal Cell / Genetic Therapy / Ki-67 Antigen Limits: Animals Language: En Journal: Eur Urol Year: 2004 Document type: Article

Search on Google

XML

PubMed Links